Valuation: Illumina, Inc.

Capitalization 20.16B 17.12B 15.81B 14.9B 27.65B 1,876B 28.13B 185B 72.62B 903B 75.63B 74.05B 3,209B P/E ratio 2026 *
28.6x
P/E ratio 2027 * 24.6x
Enterprise value 19.89B 16.89B 15.6B 14.7B 27.27B 1,851B 27.75B 183B 71.64B 890B 74.62B 73.06B 3,166B EV / Sales 2026 *
4.39x
EV / Sales 2027 * 3.97x
Free-Float
79.72%
Yield 2026 *
-
Yield 2027 * -
1 day+0.35%
1 week+7.32%
Current month+7.67%
1 month+11.27%
3 months-6.30%
6 months+38.38%
Current year+1.19%
1 week 120.6
Extreme 120.6049
133.37
1 month 116.74
Extreme 116.735
133.37
Current year 112.65
Extreme 112.65
155.53
1 year 69.83
Extreme 69.83
155.53
3 years 68.7
Extreme 68.7
232.23
5 years 68.7
Extreme 68.7
526
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 24/09/2023
Director of Finance/CFO 50 14/04/2024
Chief Tech/Sci/R&D Officer 55 28/05/2025
Director TitleAgeSince
Director/Board Member 71 28/11/2012
Director/Board Member 70 27/01/2016
Director/Board Member 65 27/07/2016
Change 5d. change 1-year change 3-years change Capi.($)
+0.35%+7.32%+80.50%-41.79% 20.16B
-2.95%+3.11%+18.13%-12.37% 192B
-2.19%+0.69%-4.83%+71.55% 163B
-2.20%+0.41%+1.64%-23.00% 137B
-1.84%+3.49%-33.42%+22.50% 94.25B
+0.22%+1.67%-14.02%-28.46% 50.39B
+1.09%-0.13%+11.03%-6.29% 45.58B
-1.27%+2.48%+15.14%-15.05% 33.42B
-0.42%+0.40%+19.06%-11.13% 33.4B
-1.78%-1.43%+6.26%+0.07% 32.59B
Average -0.74%+2.13%+9.95%-4.40% 80.14B
Weighted average by Cap. -1.38%+2.34%+3.16%+5.99%

Financials

2026 *2027 *
Net sales 4.53B 3.85B 3.56B 3.35B 6.22B 422B 6.33B 41.67B 16.33B 203B 17.01B 16.66B 722B 4.79B 4.07B 3.76B 3.54B 6.57B 446B 6.68B 44.02B 17.25B 214B 17.97B 17.59B 762B
Net income 753M 640M 591M 557M 1.03B 70.09B 1.05B 6.92B 2.71B 33.72B 2.83B 2.77B 120B 875M 743M 686M 647M 1.2B 81.43B 1.22B 8.04B 3.15B 39.17B 3.28B 3.21B 139B
Net Debt -271M -230M -212M -200M -371M -25.17B -377M -2.49B -974M -12.11B -1.01B -994M -43.06B -1.15B -979M -904M -852M -1.58B -107B -1.61B -10.59B -4.15B -51.6B -4.32B -4.23B -183B
Logo Illumina, Inc.
Illumina, Inc. is engaged in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Its products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its product categories include Instruments, Kits & Reagents, Selection Tools, and Software & Analysis. Its Instruments category include sequencing platforms, microarray scanners, and IVD instruments. Its Kits & Reagents category consists of library preparation kits, sequencing reagents, microarray kits, clinical research products, and IVD products. Its Selection Tools category include Library Prep & Array Kit Selector, Gene Panel & Array Finder, DesignStudio Custom Assay Designer, and other. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training. It is also a developer of an emerging and highly differentiated single-cell technology.
Employees
8,625
Date Price Change Volume
16/04/26 132.72 $ +0.35% 1,325,563
15/04/26 132.26 $ +1.49% 1,461,671
14/04/26 130.32 $ +2.65% 1,317,608
13/04/26 126.96 $ +4.99% 1,350,624
10/04/26 120.93 $ -2.22% 1,805,754
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
132.72USD
Average target price
136.11USD
Spread / Average Target
+2.56%

Quarterly revenue - Rate of surprise